Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis (2020)
- Authors:
- USP affiliated authors: LACCHINI, RICCARDO - EERP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: EERP; FMRP
- DOI: 10.1186/s12872-020-01412-5
- Subjects: METALOPROTEINASES; BIOMARCADORES; CARDIOLOGIA; HIPERTENSÃO; FISIOPATOLOGIA; ESTUDOS TRANSVERSAIS
- Keywords: Matrix metalloproteinase; Cardiac biomarkers; Hypertension; Emergency; Cardiovascular pathophysiology
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: BMC Cardiovascular Disorders
- ISSN: 1471-2261
- Volume/Número/Paginação/Ano: v. 20, art. 132, p. 1-7, 2020
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
VALENTE, Flavia Mariana et al. Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis. BMC Cardiovascular Disorders, v. 20, p. 1-7, 2020Tradução . . Disponível em: https://doi.org/10.1186/s12872-020-01412-5. Acesso em: 27 dez. 2025. -
APA
Valente, F. M., Andrade, D. O. de, Cosenso-Martin, L. N., Cesarino, C. B., Guimarães, S. M., Guimarães, V. B., et al. (2020). Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis. BMC Cardiovascular Disorders, 20, 1-7. doi:10.1186/s12872-020-01412-5 -
NLM
Valente FM, Andrade DO de, Cosenso-Martin LN, Cesarino CB, Guimarães SM, Guimarães VB, Lacchini R, Tanus-Santos JE, Yugar-Toledo JC, Vilela-Martin JF. Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis [Internet]. BMC Cardiovascular Disorders. 2020 ; 20 1-7.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1186/s12872-020-01412-5 -
Vancouver
Valente FM, Andrade DO de, Cosenso-Martin LN, Cesarino CB, Guimarães SM, Guimarães VB, Lacchini R, Tanus-Santos JE, Yugar-Toledo JC, Vilela-Martin JF. Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis [Internet]. BMC Cardiovascular Disorders. 2020 ; 20 1-7.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1186/s12872-020-01412-5 - Interethnic differences in the distribution of matrix metalloproteinases genetic polymorphisms are consistent with interethnic differences in disease prevalence
- Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases
- Increased activity of MMP-2 in hypertensive obese children is associated with hypoadiponectinemia
- Effect of genetic polymorphisms of vascular endothelial growth factor on left ventricular hypertrophy in patients with systemic hypertension
- Polymorphisms in VEGFA gene affect the antihypertensive responses to enalapril
- Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients
- The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity
- Endothelial nitric oxide synthase: from biochemistry and gene structure to clinical implications of NOS3 polymorphisms
- Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease
- The effects of endothelial nitric oxide synthase tagSNPs on nitrite levels and risk of hypertension and obesity in children and adolescents
Informações sobre o DOI: 10.1186/s12872-020-01412-5 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003029583.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
